• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影响 CDKL5 缺乏症患儿主要运动里程碑达成的因素。

Factors influencing the attainment of major motor milestones in CDKL5 deficiency disorder.

机构信息

Telethon Kids Institute, The University of Western Australia, Perth, WA, Australia.

Children's Hospital Colorado, Pediatric Neurology, University of Colorado School of Medicine, Aurora, USA.

出版信息

Eur J Hum Genet. 2023 Feb;31(2):169-178. doi: 10.1038/s41431-022-01163-1. Epub 2022 Aug 18.

DOI:10.1038/s41431-022-01163-1
PMID:35978140
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9905550/
Abstract

This study investigated the influence of factors at birth and in infancy on the likelihood of achieving major motor milestones in CDKL5 Deficiency Disorder (CDD). Data on 350 individuals with a pathogenic CDKL5 variant was sourced from the International CDKL5 Disorder Database. A first model included factors available at birth (e.g., sex, variant group and mosaicism) and the second additionally included factors available during infancy (e.g., age at seizure onset, number of anti-seizure medications used, experience of a honeymoon period and formal therapy). Cox regression was used to model the time to achieve the milestones. The probability of attaining the outcomes at specific ages was estimated by evaluating the time-to-event function at specific covariate values. Independent sitting and walking were achieved by 177/350 and 57/325 children respectively. By seven years of age, 67.1% of females but only 37.3% of males could sit independently. About a quarter each of females and males achieved independent walking by eight and six years, respectively. When observed from birth, female gender, a late truncating variant and mosaicism impacted most positively on the likelihood of independent sitting. When observed from one year, later seizure onset and experiencing a honeymoon period also improved the likelihood of independent sitting. Factors that favoured sitting (except gender) also improved walking. Having a truncating variant between aa178 and aa781 reduced the likelihood of achieving independent sitting and walking. It is possible to utilise factors occurring early in life to inform the likelihood of future motor development in CDD.

摘要

本研究调查了出生和婴儿期因素对 CDKL5 缺乏症(CDD)患者达到主要运动里程碑的可能性的影响。350 名携带致病性 CDKL5 变异体的个体数据来源于国际 CDKL5 障碍数据库。第一个模型包括出生时可获得的因素(例如,性别、变异体组和镶嵌性),第二个模型还包括婴儿期可获得的因素(例如,癫痫发作开始的年龄、使用的抗癫痫药物数量、蜜月期经历和正式治疗)。使用 Cox 回归来建立里程碑的时间模型。通过评估特定协变量值的时间事件函数来估计特定年龄达到结果的概率。177/350 的儿童独立坐着,57/325 的儿童独立行走。7 岁时,67.1%的女性可以独立坐着,而只有 37.3%的男性可以独立坐着。大约四分之一的女性和男性分别在 8 岁和 6 岁时独立行走。从出生开始观察时,女性性别、晚期截断变异体和镶嵌性对独立坐着的可能性影响最大。从一岁开始观察时,癫痫发作较晚和蜜月期的经历也提高了独立坐着的可能性。有利于坐着的因素(除了性别)也提高了行走的可能性。aa178 和 aa781 之间的截断变异体减少了独立坐着和行走的可能性。利用生命早期发生的因素可以告知 CDD 未来运动发育的可能性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c999/9905550/1266966a206f/41431_2022_1163_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c999/9905550/2130416fc0de/41431_2022_1163_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c999/9905550/cde5b7b9ae03/41431_2022_1163_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c999/9905550/d5e4728d1794/41431_2022_1163_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c999/9905550/1266966a206f/41431_2022_1163_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c999/9905550/2130416fc0de/41431_2022_1163_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c999/9905550/cde5b7b9ae03/41431_2022_1163_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c999/9905550/d5e4728d1794/41431_2022_1163_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c999/9905550/1266966a206f/41431_2022_1163_Fig4_HTML.jpg

相似文献

1
Factors influencing the attainment of major motor milestones in CDKL5 deficiency disorder.影响 CDKL5 缺乏症患儿主要运动里程碑达成的因素。
Eur J Hum Genet. 2023 Feb;31(2):169-178. doi: 10.1038/s41431-022-01163-1. Epub 2022 Aug 18.
2
CDKL5 deficiency disorder: Relationship between genotype, epilepsy, cortical visual impairment, and development.CDKL5 缺乏症:基因型、癫痫、皮质性视觉障碍与发育的关系。
Epilepsia. 2019 Aug;60(8):1733-1742. doi: 10.1111/epi.16285. Epub 2019 Jul 16.
3
There is variability in the attainment of developmental milestones in the CDKL5 disorder.在CDKL5障碍中,发育里程碑的达成存在变异性。
J Neurodev Disord. 2015;7(1):2. doi: 10.1186/1866-1955-7-2. Epub 2015 Jan 5.
4
X-linked cellular mosaicism underlies age-dependent occurrence of seizure-like events in mouse models of CDKL5 deficiency disorder.X 连锁细胞嵌合导致 CDKL5 缺乏症小鼠模型中癫痫样发作事件的发生具有年龄依赖性。
Neurobiol Dis. 2021 Jan;148:105176. doi: 10.1016/j.nbd.2020.105176. Epub 2020 Nov 13.
5
Functional abilities in children and adults with the CDKL5 disorder.患有CDKL5障碍的儿童和成人的功能能力。
Am J Med Genet A. 2016 Nov;170(11):2860-2869. doi: 10.1002/ajmg.a.37851. Epub 2016 Aug 16.
6
CDKL5 deficiency disorder in males: Five new variants and review of the literature.男性 CDKL5 缺乏症:五个新变异体及文献复习。
Eur J Paediatr Neurol. 2021 Jul;33:9-20. doi: 10.1016/j.ejpn.2021.04.007. Epub 2021 Apr 30.
7
Clinical manifestation of CDKL5 deficiency disorder and identified mutations in a cohort of Slovak patients.斯洛伐克患者队列中CDKL5缺乏症的临床表现及已鉴定的突变
Epilepsy Res. 2021 Oct;176:106699. doi: 10.1016/j.eplepsyres.2021.106699. Epub 2021 Jun 23.
8
Exploring quality of life in individuals with a severe developmental and epileptic encephalopathy, CDKL5 Deficiency Disorder.探讨患有严重发育性和癫痫性脑病、CDKL5 缺乏症个体的生活质量。
Epilepsy Res. 2021 Jan;169:106521. doi: 10.1016/j.eplepsyres.2020.106521. Epub 2020 Dec 1.
9
Seizure variables and their relationship to genotype and functional abilities in the CDKL5 disorder.CDKL5障碍中的癫痫发作变量及其与基因型和功能能力的关系。
Neurology. 2016 Nov 22;87(21):2206-2213. doi: 10.1212/WNL.0000000000003352. Epub 2016 Oct 21.
10
CDKL5 deficiency causes epileptic seizures independent of cellular mosaicism.CDKL5 缺乏症导致癫痫发作,与细胞嵌合体无关。
J Neurol Sci. 2022 Dec 15;443:120498. doi: 10.1016/j.jns.2022.120498. Epub 2022 Nov 16.

引用本文的文献

1
CDKL5 Deficiency Disorder: Revealing the Molecular Mechanism of Pathogenic Variants.CDKL5缺陷障碍:揭示致病变异的分子机制
Int J Mol Sci. 2025 Aug 29;26(17):8399. doi: 10.3390/ijms26178399.
2
Cannabinoids and Genetic Epilepsy Models: A Review with Focus on CDKL5 Deficiency Disorder.大麻素与遗传性癫痫模型:以 CDKL5 缺乏症为重点的综述。
Int J Mol Sci. 2024 Oct 7;25(19):10768. doi: 10.3390/ijms251910768.
3
Psychometric evaluation of clinician- and caregiver-reported clinical severity assessments for individuals with CDKL5 deficiency disorder.

本文引用的文献

1
Influences on the trajectory and subsequent outcomes in CDKL5 deficiency disorder.对CDKL5缺乏症的病程及后续结局的影响。
Epilepsia. 2022 Feb;63(2):352-363. doi: 10.1111/epi.17125. Epub 2021 Nov 27.
2
Cerebral visual impairment in CDKL5 deficiency disorder: vision as an outcome measure.CDKL5 缺乏症中的脑性视觉障碍:以视力作为评估指标。
Dev Med Child Neurol. 2021 Nov;63(11):1308-1315. doi: 10.1111/dmcn.14908. Epub 2021 May 24.
3
Exploring quality of life in individuals with a severe developmental and epileptic encephalopathy, CDKL5 Deficiency Disorder.
CDKL5 缺乏症患者的临床医生和照顾者报告的临床严重程度评估的心理测量学评估。
Epilepsia. 2024 Oct;65(10):3064-3075. doi: 10.1111/epi.18094. Epub 2024 Aug 27.
4
Caregiver Perspective of Benefits and Side Effects of Anti-Seizure Medications in CDKL5 Deficiency Disorder from an International Database.国际数据库中 CDKL5 缺乏症患者照顾者对抗癫痫药物的获益和副作用的看法。
CNS Drugs. 2024 Sep;38(9):719-732. doi: 10.1007/s40263-024-01105-z. Epub 2024 Jul 26.
5
CDKL5 Deficiency Disorder: Some Lessons Learned 20 Years After the First Description.CDKL5 缺乏症:首例描述 20 年后的一些经验教训。
Am J Intellect Dev Disabil. 2024 Mar 1;129(2):101-109. doi: 10.1352/1944-7558-129.2.101.
6
Adapting a measure of gross motor skills for individuals with CDKL5 deficiency disorder: A psychometric study.为患有CDKL5缺陷障碍的个体改编一项粗大运动技能测量方法:一项心理测量学研究。
Epilepsy Res. 2024 Feb;200:107287. doi: 10.1016/j.eplepsyres.2024.107287. Epub 2024 Jan 15.
7
Discovery and characterization of a specific inhibitor of serine-threonine kinase cyclin-dependent kinase-like 5 (CDKL5) demonstrates role in hippocampal CA1 physiology.发现并鉴定丝氨酸-苏氨酸激酶细胞周期依赖性激酶样 5(CDKL5)的特异性抑制剂,证明其在海马 CA1 生理学中的作用。
Elife. 2023 Jul 25;12:e88206. doi: 10.7554/eLife.88206.
8
The value of exomes across the ages.不同年龄段外显子组的价值。
Eur J Hum Genet. 2023 Feb;31(2):129-130. doi: 10.1038/s41431-023-01281-4.
探讨患有严重发育性和癫痫性脑病、CDKL5 缺乏症个体的生活质量。
Epilepsy Res. 2021 Jan;169:106521. doi: 10.1016/j.eplepsyres.2020.106521. Epub 2020 Dec 1.
4
Exploring genotype-phenotype relationships in the CDKL5 deficiency disorder using an international dataset.利用国际数据集探索 CDKL5 缺乏症的基因型-表型关系。
Clin Genet. 2021 Jan;99(1):157-165. doi: 10.1111/cge.13862. Epub 2020 Oct 20.
5
Comparison of Core Features in Four Developmental Encephalopathies in the Rett Natural History Study.在雷特自然史研究中,四种发育性脑病的核心特征比较。
Ann Neurol. 2020 Aug;88(2):396-406. doi: 10.1002/ana.25797. Epub 2020 Jun 29.
6
Proof-of-concept for a gene replacement approach to CDKL5 deficiency disorder.针对 CDKL5 缺乏症的基因替换方法的概念验证。
Brain. 2020 Mar 1;143(3):716-718. doi: 10.1093/brain/awaa055.
7
Epilepsy and developmental disorders: Next generation sequencing in the clinic.癫痫与发育障碍:临床中的新一代测序技术。
Eur J Paediatr Neurol. 2020 Jan;24:15-23. doi: 10.1016/j.ejpn.2019.12.008. Epub 2019 Dec 18.
8
Predicting Long-Term Survival Without Major Disability for Infants Born Preterm.预测极早产儿长期无重大残疾生存。
J Pediatr. 2019 Dec;215:90-97.e1. doi: 10.1016/j.jpeds.2019.07.056. Epub 2019 Sep 4.
9
CDKL5 deficiency disorder: Relationship between genotype, epilepsy, cortical visual impairment, and development.CDKL5 缺乏症:基因型、癫痫、皮质性视觉障碍与发育的关系。
Epilepsia. 2019 Aug;60(8):1733-1742. doi: 10.1111/epi.16285. Epub 2019 Jul 16.
10
Incidence and phenotypes of childhood-onset genetic epilepsies: a prospective population-based national cohort.儿童起病遗传性癫痫的发病率和表型:一项前瞻性基于人群的全国队列研究。
Brain. 2019 Aug 1;142(8):2303-2318. doi: 10.1093/brain/awz195.